Wikiproyecto:Medicina/Cochrane/Revisiones Cochrane en es.Wikipedia/Cochrane Children and Families

Cochrane Children and Families:
Revisiones que pueden ser consideradas para Wikipedia

Cystic Fibrosis and Genetic Disorders Group[editar]

01/11/2012 Macrolide antibiotics for cystic fibrosis PMID:23152214.0 https://doi.org/10.1002/14651858.CD002203.pub4

01/12/2012 Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis PMID:23235645.0 https://doi.org/10.1002/14651858.CD007481.pub3

01/12/2020 Respiratory muscle training for cystic fibrosis PMID:33331663.0 https://doi.org/10.1002/14651858.CD006112.pub5

01/12/2020 Tyrosine supplementation for phenylketonuria PMID:nan https://doi.org/10.1002/14651858.CD001507.pub4

01/12/2020 Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del) PMID:33331662.0 https://doi.org/10.1002/14651858.CD010966.pub3

01/11/2020 Gene therapy for sickle cell disease PMID:33251574.0 https://doi.org/10.1002/14651858.CD007652.pub7

01/10/2020 Drug treatments for managing cystic fibrosis-related diabetes PMID:33075159.0 https://doi.org/10.1002/14651858.CD004730.pub5

01/09/2020 Phytomedicines (medicines derived from plants) for sickle cell disease PMID:32977351.0 https://doi.org/10.1002/14651858.CD004448.pub7

01/09/2020 Pine bark (Pinus spp.) extract for treating chronic disorders PMID:32990945.0 https://doi.org/10.1002/14651858.CD008294.pub5

01/09/2020 Prophylactic anti-staphylococcal antibiotics for cystic fibrosis PMID:32997797.0 https://doi.org/10.1002/14651858.CD001912.pub5

01/09/2020 Vitamin E supplementation in people with cystic fibrosis PMID:32892350.0 https://doi.org/10.1002/14651858.CD009422.pub4

01/08/2020 Pancreatic enzyme replacement therapy for people with cystic fibrosis PMID:32761612.0 https://doi.org/10.1002/14651858.CD008227.pub4

01/08/2020 Rituximab for treating inhibitors in people with inherited severe hemophilia PMID:32761818.0 https://doi.org/10.1002/14651858.CD010810.pub4

01/07/2020 Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis PMID:32671834.0 https://doi.org/10.1002/14651858.CD008037.pub4

01/07/2020 Dietary interventions for phenylketonuria PMID:32672365.0 https://doi.org/10.1002/14651858.CD001304.pub3

01/07/2020 Preoperative blood transfusions for sickle cell disease PMID:32614473.0 https://doi.org/10.1002/14651858.CD003149.pub4

01/07/2020 Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease PMID:32716555.0 https://doi.org/10.1002/14651858.CD003146.pub4

01/07/2020 Hematopoietic stem cell transplantation for people with sickle cell disease PMID:32617981.0 https://doi.org/10.1002/14651858.CD007001.pub5

01/06/2020 Interventions for treating intrahepatic cholestasis in people with sickle cell disease PMID:32567054.0 https://doi.org/10.1002/14651858.CD010985.pub4

01/06/2020 Vitamin K supplementation for cystic fibrosis PMID:32497260.0 https://doi.org/10.1002/14651858.CD008482.pub6

01/06/2020 Newborn screening for galactosaemia PMID:32567677.0 https://doi.org/10.1002/14651858.CD012272.pub3

01/06/2020 Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis PMID:32520436.0 https://doi.org/10.1002/14651858.CD009528.pub5

01/06/2020 Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis PMID:32521055.0 https://doi.org/10.1002/14651858.CD010004.pub5

01/05/2020 Inhaled mannitol for cystic fibrosis PMID:32358807.0 https://doi.org/10.1002/14651858.CD008649.pub4

01/05/2020 Vitamin D supplementation for sickle cell disease PMID:32462740.0 https://doi.org/10.1002/14651858.CD010858.pub3

01/05/2020 Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis PMID:32412092.0 https://doi.org/10.1002/14651858.CD006961.pub5

01/05/2020 Growth hormone therapy for people with thalassaemia PMID:32463488.0 https://doi.org/10.1002/14651858.CD012284.pub3

01/04/2020 Gene therapy for haemophilia PMID:32342499.0 https://doi.org/10.1002/14651858.CD010822.pub4

01/04/2020 Omega-3 fatty acid supplementation for cystic fibrosis PMID:32275788.0 https://doi.org/10.1002/14651858.CD002201.pub6

01/04/2020 Interventions for preventing silent cerebral infarcts in people with sickle cell disease PMID:32250453.0 https://doi.org/10.1002/14651858.CD012389.pub3

01/04/2020 Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation PMID:32239690.0 https://doi.org/10.1002/14651858.CD009529.pub4

01/04/2020 Oscillating devices for airway clearance in people with cystic fibrosis PMID:32352564.0 https://doi.org/10.1002/14651858.CD006842.pub5

01/04/2020 Palliative drug treatments for breathlessness in cystic fibrosis PMID:32343850.0 https://doi.org/10.1002/14651858.CD011855.pub3

01/04/2020 Treatments for priapism in boys and men with sickle cell disease PMID:32251534.0 https://doi.org/10.1002/14651858.CD004198.pub4

01/03/2020 Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease PMID:32124977.0 https://doi.org/10.1002/14651858.CD012762.pub2

01/03/2020 Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia PMID:32190901.0 https://doi.org/10.1002/14651858.CD012517.pub2

01/03/2020 Psychological interventions for people with hemophilia PMID:32187661.0 https://doi.org/10.1002/14651858.CD010215.pub2

01/03/2020 Interventions for preventing and managing advanced liver disease in cystic fibrosis PMID:32227478.0 https://doi.org/10.1002/14651858.CD012056.pub3

01/03/2020 Physical therapies for postural abnormalities in people with cystic fibrosis PMID:32227599.0 https://doi.org/10.1002/14651858.CD013018.pub2

01/03/2020 Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis PMID:32189337.0 https://doi.org/10.1002/14651858.CD009249.pub5

01/02/2020 Timing of hypertonic saline inhalation for cystic fibrosis PMID:32107770.0 https://doi.org/10.1002/14651858.CD008816.pub4

01/01/2020 Blood transfusions for treating acute chest syndrome in people with sickle cell disease PMID:31942751.0 https://doi.org/10.1002/14651858.CD007843.pub4

01/01/2020 Probiotics for people with cystic fibrosis PMID:31962375.0 https://doi.org/10.1002/14651858.CD012949.pub2

01/09/2019 Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis PMID:31483853.0 https://doi.org/10.1002/14651858.CD002009.pub7

01/09/2019 Splenectomy for people with thalassaemia major or intermedia PMID:31529486.0 https://doi.org/10.1002/14651858.CD010517.pub3

01/09/2019 Magnesium for treating sickle cell disease PMID:31498421.0 https://doi.org/10.1002/14651858.CD011358.pub3

01/09/2019 Antibiotics for treating acute chest syndrome in people with sickle cell disease PMID:31531967.0 https://doi.org/10.1002/14651858.CD006110.pub5

01/09/2019 Duration of intravenous antibiotic therapy in people with cystic fibrosis PMID:31487382.0 https://doi.org/10.1002/14651858.CD006682.pub6

01/09/2019 Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis PMID:31499593.0 https://doi.org/10.1002/14651858.CD001505.pub5

01/08/2019 Treatment of dental and orthodontic complications in thalassaemia PMID:31425614.0 https://doi.org/10.1002/14651858.CD012969.pub2

01/07/2019 Inhaled corticosteroids for cystic fibrosis PMID:31271656.0 https://doi.org/10.1002/14651858.CD001915.pub6

01/07/2019 Enteral tube feeding for cystic fibrosis PMID:31328789.0 https://doi.org/10.1002/14651858.CD001198.pub5

01/07/2019 Singing as an adjunct therapy for children and adults with cystic fibrosis PMID:31425607.0 https://doi.org/10.1002/14651858.CD008036.pub5

01/07/2019 Interventions for treating neuropathic pain in people with sickle cell disease PMID:31273755.0 https://doi.org/10.1002/14651858.CD012943.pub2

01/06/2019 Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis PMID:31194880.0 https://doi.org/10.1002/14651858.CD013079.pub2

01/06/2019 Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I PMID:31211405.0 https://doi.org/10.1002/14651858.CD009354.pub5